Researchers have developed a new tool that can predict advanced liver fibrosis in people with diabetes. The instrument may be the first scoring system designed specifically for a patient population at high risk for advanced, fast-progressing liver disease.
In a retrospective study of almost 600 patients with type 2 diabetes who had undergone liver biopsy, the noninvasive method outperformed existing approaches to predicting fibrosis, according to its developers. The researchers, from the